Page last updated: 2024-10-18

dihydroxyphenylalanine and Cancer of the Thyroid

dihydroxyphenylalanine has been researched along with Cancer of the Thyroid in 37 studies

Dihydroxyphenylalanine: A beta-hydroxylated derivative of phenylalanine. The D-form of dihydroxyphenylalanine has less physiologic activity than the L-form and is commonly used experimentally to determine whether the pharmacological effects of LEVODOPA are stereospecific.
dopa : A hydroxyphenylalanine carrying hydroxy substituents at positions 3 and 4 of the benzene ring.

Research Excerpts

ExcerptRelevanceReference
"(18)F-fluorodihydroxyphenylalanine (FDOPA) is a powerful tool for the diagnosis and detection of neuroendocrine tumors when planning and monitoring surgical and oncologic therapies."8.9018F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. ( Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M, 2014)
"In recent years, 6-l-18F-fluorodihydroxyphenylalanine (18F-DOPA) PET has emerged as a new diagnostic tool for the imaging of neuroendocrine tumors."8.846-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. ( Brouwers, AH; Chirakal, R; Gulenchyn, KY; Jager, PL; Koopmans, KP; Marriott, CJ, 2008)
"(18)F-fluorodihydroxyphenylalanine (FDOPA) is a powerful tool for the diagnosis and detection of neuroendocrine tumors when planning and monitoring surgical and oncologic therapies."4.9018F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors. ( Forsback, S; Kauhanen, S; Kemppainen, J; Minn, H; Seppänen, M, 2014)
"In recent years, 6-l-18F-fluorodihydroxyphenylalanine (18F-DOPA) PET has emerged as a new diagnostic tool for the imaging of neuroendocrine tumors."4.846-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications. ( Brouwers, AH; Chirakal, R; Gulenchyn, KY; Jager, PL; Koopmans, KP; Marriott, CJ, 2008)
"11 C-methionine was most sensitive in lung lesions."3.01Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review. ( Li, P; Wei, T; Xu, T; Zhang, Y; Zhao, W; Zhu, J, 2023)
"Medullary thyroid cancer (MTC) is considered as a rare thyroid cancer."2.5018F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports. ( Evangelista, L; Farsad, M; Pelizzo, MR; Piotto, A, 2014)

Research

Studies (37)

TimeframeStudies, this research(%)All Research%
pre-19902 (5.41)18.7374
1990's0 (0.00)18.2507
2000's4 (10.81)29.6817
2010's29 (78.38)24.3611
2020's2 (5.41)2.80

Authors

AuthorsStudies
Li, P1
Zhang, Y1
Xu, T1
Zhu, J1
Wei, T1
Zhao, W1
Rotania, M1
Chabrier, G2
Imperiale, A4
Taralli, S1
Lorusso, M1
Capotosti, A1
Lanni, V1
Indovina, L1
Rufini, V5
Golubić, AT1
Pasini Nemir, E1
Žuvić, M1
Mutvar, A1
Kusačić Kuna, S1
Despot, M1
Samardžić, T1
Huić, D1
Rasul, S1
Hartenbach, S1
Rebhan, K1
Göllner, A1
Karanikas, G3
Mayerhoefer, M2
Mazal, P1
Hacker, M1
Hartenbach, M1
Brammen, L1
Niederle, MB1
Riss, P1
Scheuba, C1
Selberherr, A1
Bodner, G1
Koperek, O1
Niederle, B1
Terroir, M1
Grimaldi, S1
Hartl, D1
Leboulleux, S1
Deandreis, D1
Balogova, S2
Talbot, JN3
Nataf, V2
Michaud, L1
Huchet, V1
Kerrou, K2
Montravers, F3
Slavikova, K1
Treglia, G5
Kunikowska, J1
Kaliska, L1
Vereb, M1
Minn, H2
Kemppainen, J1
Kauhanen, S2
Forsback, S1
Seppänen, M2
Santhanam, P1
Taïeb, D2
Evangelista, L1
Farsad, M1
Piotto, A1
Pelizzo, MR2
Sesti, A1
Weber, M1
Anner, P1
Wadsak, W1
Dudczak, R1
Haug, A1
Shamim, SA1
Kumar, A1
Kumar, R1
Archier, A1
Heimburger, C1
Guerin, C1
Morange, I1
Palazzo, FF1
Henry, JF1
Schneegans, O2
Mundler, O1
Abdullah, AE1
Sebag, F1
Ruiz, JB1
Orré, M1
Cazeau, AL1
Henriques de Figueiredo, B1
Godbert, Y1
Beheshti, M1
Pöcher, S1
Vali, R1
Waldenberger, P1
Broinger, G1
Nader, M1
Kohlfürst, S1
Pirich, C1
Dralle, H2
Langsteger, W1
Pestourie, C1
Thézé, B1
Kuhnast, B1
Le Helleix, S1
Gombert, K1
Dollé, F1
Tavitian, B1
Ducongé, F1
Ambrosini, V4
Marzola, MC2
Rubello, D2
Fanti, S4
Ferdeghini, M1
Toniato, A1
Massaro, A1
Gross, MD1
Al-Nahhas, A1
Morel, O1
Giraud, P1
Cahouet, A1
Lacoeuille, F1
Girault, S1
Luster, M1
Karges, W1
Zeich, K1
Pauls, S1
Verburg, FA1
Glatting, G1
Buck, AK1
Solbach, C1
Neumaier, B1
Reske, SN1
Mottaghy, FM1
Greget, M1
Keomany, J1
Rust, E2
Detour, J1
Pessaux, P1
Goichot, B1
Walter, MA1
Benz, MR1
Hildebrandt, IJ1
Laing, RE1
Hartung, V1
Damoiseaux, RD1
Bockisch, A1
Phelps, ME1
Czernin, J1
Weber, WA1
Schalin-Jäntti, C1
Kajander, S1
Virtanen, S1
Schildt, J1
Lisinen, I1
Ahonen, A1
Heiskanen, I1
Väisänen, M1
Arola, J1
Korsoff, P1
Ebeling, T1
Sane, T1
Välimäki, MJ1
Nuutila, P1
Castaldi, P3
Villani, MF2
Perotti, G2
de Waure, C2
Filice, A2
Cremonini, N2
Santimaria, M1
Versari, A2
Giordano, A3
Soussan, M1
Grahek, D1
Pascal, O1
Boulanger, C1
Roedlich, MN1
Ollier, JC1
Cocciolillo, F1
Di Nardo, F1
Poscia, A1
Verbeek, HH1
Plukker, JT1
Koopmans, KP2
de Groot, JW1
Hofstra, RM1
Muller Kobold, AC1
van der Horst-Schrivers, AN1
Brouwers, AH2
Links, TP1
Beuthien-Baumann, B1
Strumpf, A1
Zessin, J1
Bredow, J1
Kotzerke, J1
Jager, PL1
Chirakal, R1
Marriott, CJ1
Gulenchyn, KY1
Hoegerle, S1
Altehoefer, C1
Ghanem, N1
Brink, I1
Moser, E1
Nitzsche, E1
Atkins, FL1
Beaven, MA1
Keiser, HR1
Beskid, M1

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
The Use of Fluorodopa F 18 Positron Emission Tomography Combined With Computed Tomography in Congenital Hyperinsulinism and Insulinoma[NCT02021604]Phase 1250 participants (Anticipated)Interventional2013-10-09Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

10 reviews available for dihydroxyphenylalanine and Cancer of the Thyroid

ArticleYear
Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
    Nuclear medicine communications, 2023, Dec-01, Volume: 44, Issue:12

    Topics: Dihydroxyphenylalanine; Humans; Methionine; Network Meta-Analysis; Positron Emission Tomography Comp

2023
18F-fluorodihydroxyphenylalanine vs other radiopharmaceuticals for imaging neuroendocrine tumours according to their type.
    European journal of nuclear medicine and molecular imaging, 2013, Volume: 40, Issue:6

    Topics: 3-Iodobenzylguanidine; Bronchial Neoplasms; Carcinoma, Merkel Cell; Dihydroxyphenylalanine; Fluorode

2013
What is currently the best radiopharmaceutical for the hybrid PET/CT detection of recurrent medullary thyroid carcinoma?
    Current radiopharmaceuticals, 2013, Jun-06, Volume: 6, Issue:2

    Topics: Amines; Blood Glucose; Bone and Bones; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Fluorine R

2013
18F-fluorodihydroxyphenylalanine in the diagnosis of neuroendocrine tumors.
    PET clinics, 2014, Volume: 9, Issue:1

    Topics: Adrenal Gland Neoplasms; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Intestinal Neopl

2014
Role of (18) F-FDOPA PET/CT imaging in endocrinology.
    Clinical endocrinology, 2014, Volume: 81, Issue:6

    Topics: Adrenal Gland Neoplasms; Carbidopa; Carcinoid Tumor; Carcinoma, Neuroendocrine; Dihydroxyphenylalani

2014
18F-DOPA and 18F-FDG PET/CT, scintigraphic localization and radioguided surgery of recurrent medullary thyroid cancer: two case reports.
    Current radiopharmaceuticals, 2014, Volume: 7, Issue:2

    Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Huma

2014
PET/Computed Tomography in Neuroendocrine Tumor: Value to Patient Management and Survival Outcomes.
    PET clinics, 2015, Volume: 10, Issue:3

    Topics: Adrenal Gland Neoplasms; Dihydroxyphenylalanine; Fluorodeoxyglucose F18; Gallium Radioisotopes; Gast

2015
Detection rate of recurrent medullary thyroid carcinoma using fluorine-18 dihydroxyphenylalanine positron emission tomography: a meta-analysis.
    Academic radiology, 2012, Volume: 19, Issue:10

    Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Positron-Emis

2012
Comparison of different positron emission tomography tracers in patients with recurrent medullary thyroid carcinoma: our experience and a review of the literature.
    Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer, 2013, Volume: 194

    Topics: Adult; Aged; Aged, 80 and over; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorodeo

2013
6-L-18F-fluorodihydroxyphenylalanine PET in neuroendocrine tumors: basic aspects and emerging clinical applications.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2008, Volume: 49, Issue:4

    Topics: Adenoma, Islet Cell; Dihydroxyphenylalanine; Humans; Hyperinsulinism; Neuroendocrine Tumors; Pancrea

2008

Trials

2 trials available for dihydroxyphenylalanine and Cancer of the Thyroid

ArticleYear
Complementary roles of 18F-DOPA PET/CT and 18F-FDG PET/CT in medullary thyroid cancer.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:12

    Topics: Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Cell Proliferation; Di

2011
18F-DOPA positron emission tomography for tumour detection in patients with medullary thyroid carcinoma and elevated calcitonin levels.
    European journal of nuclear medicine, 2001, Volume: 28, Issue:1

    Topics: Aged; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Huma

2001

Other Studies

25 other studies available for dihydroxyphenylalanine and Cancer of the Thyroid

ArticleYear
Synchronous bilateral pheochromocytomas and bilobar medullary thyroid carcinoma revealed by
    Endocrine, 2019, Volume: 66, Issue:3

    Topics: Adrenal Gland Neoplasms; Adult; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; M

2019
Which Is the Optimal Scan Time of 18F-DOPA PET/CT in Patients With Recurrent Medullary Thyroid Carcinoma?: Results From a Dynamic Acquisition Study.
    Clinical nuclear medicine, 2020, Volume: 45, Issue:3

    Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Image Processing, Computer-Assist

2020
The value of 18F-DOPA PET/CT in patients with medullary thyroid carcinoma and increased calcitonin values.
    Nuclear medicine communications, 2017, Volume: 38, Issue:7

    Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyp

2017
[
    European journal of nuclear medicine and molecular imaging, 2018, Volume: 45, Issue:12

    Topics: Adult; Aged; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; P

2018
Medullary Thyroid Carcinoma: Do Ultrasonography and F-DOPA-PET-CT Influence the Initial Surgical Strategy?
    Annals of surgical oncology, 2018, Volume: 25, Issue:13

    Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Neuroendocrine; Child; Clinical Decision-Making; Dih

2018
Parathyroid Glands Hyperplasias Mimicking Medullary Thyroid Carcinoma Metastatic Lymph Nodes on 18F-DOPA PET/CT.
    Clinical nuclear medicine, 2019, Volume: 44, Issue:8

    Topics: Adult; Carcinoma, Neuroendocrine; Diagnosis, Differential; Dihydroxyphenylalanine; Female; Fluorine

2019
Relevance of calcitonin cut-off in the follow-up of medullary thyroid carcinoma for conventional imaging and 18-fluorine-fluorodihydroxyphenylalanine PET.
    Anticancer research, 2014, Volume: 34, Issue:11

    Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fo

2014
(18)F-DOPA PET/CT in the diagnosis and localization of persistent medullary thyroid carcinoma.
    European journal of nuclear medicine and molecular imaging, 2016, Volume: 43, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Femal

2016
18F-DOPA PET/CT in Orbital Metastasis From Medullary Thyroid Carcinoma.
    Clinical nuclear medicine, 2016, Volume: 41, Issue:6

    Topics: Adult; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Fluorine Radioisotopes

2016
The value of 18F-DOPA PET-CT in patients with medullary thyroid carcinoma: comparison with 18F-FDG PET-CT.
    European radiology, 2009, Volume: 19, Issue:6

    Topics: Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission

2009
PET imaging of medullary thyroid carcinoma in MEN2A transgenic mice using 6-[(18)F]F-L-DOPA.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:1

    Topics: Animals; Carcinoma, Medullary; Dihydroxyphenylalanine; Mice; Mice, Transgenic; Multiple Endocrine Ne

2010
(68)Ga-somatostatin analogues PET and (18)F-DOPA PET in medullary thyroid carcinoma.
    European journal of nuclear medicine and molecular imaging, 2010, Volume: 37, Issue:1

    Topics: Carcinoma, Medullary; Dihydroxyphenylalanine; Humans; Neoplasm Recurrence, Local; Organometallic Com

2010
Dual PET/CT with (18)F-DOPA and (18)F-FDG in metastatic medullary thyroid carcinoma and rapidly increasing calcitonin levels: Comparison with conventional imaging.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2010, Volume: 36, Issue:4

    Topics: Adult; Aged; Biomarkers, Tumor; Calcitonin; Carcinoma, Medullary; Chi-Square Distribution; Dihydroxy

2010
Visualization of cardiac metastasis from medullary thyroid carcinoma on F-18 DOPA PET/CT scan.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:4

    Topics: Carcinoma; Dihydroxyphenylalanine; Female; Heart Neoplasms; Humans; Middle Aged; Positron-Emission T

2010
Clinical value of 18-fluorine-fluorodihydroxyphenylalanine positron emission tomography/computed tomography in the follow-up of medullary thyroid carcinoma.
    Thyroid : official journal of the American Thyroid Association, 2010, Volume: 20, Issue:5

    Topics: Adolescent; Adult; Aged; Calcitonin; Carcinoma, Medullary; Child; Dihydroxyphenylalanine; Disease Pr

2010
Solitary hepatic metastasis from medullary thyroid carcinoma mimicking atypical hemangioma: insights from multimodality diagnostic approach by MRI, F-18 FDG and F-18 FDOPA PET/CT.
    Clinical nuclear medicine, 2010, Volume: 35, Issue:6

    Topics: Diagnosis, Differential; Diagnostic Imaging; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18;

2010
Metabolic imaging allows early prediction of response to vandetanib.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2011, Volume: 52, Issue:2

    Topics: Aged; Animals; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Cyclins; Dihydroxyphenylalanine; Do

2011
Comparison of 18F-DOPA, 18F-FDG and 68Ga-somatostatin analogue PET/CT in patients with recurrent medullary thyroid carcinoma.
    European journal of nuclear medicine and molecular imaging, 2012, Volume: 39, Issue:4

    Topics: Adult; Aged; Aged, 80 and over; Calcitonin; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Femal

2012
Added value of early 18F-FDOPA PET/CT acquisition time in medullary thyroid cancer.
    Nuclear medicine communications, 2012, Volume: 33, Issue:7

    Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Humans; Male; Middle Aged; Multim

2012
Terminal ileum neuroendocrine incidentaloma in a patient with sporadic medullary thyroid carcinoma: findings from 18F-FDOPA PET/CT investigation.
    Clinical nuclear medicine, 2012, Volume: 37, Issue:8

    Topics: Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Female; Humans; Ileal Neoplasms; Incidental Findi

2012
Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2012, Volume: 53, Issue:12

    Topics: Adult; Aged; Carcinoembryonic Antigen; Carcinoma, Neuroendocrine; Dihydroxyphenylalanine; Disease Pr

2012
(18)F-DOPA PET/CT revealed synchronous neuroendocrine tumors in two sisters with MEN2A syndrome.
    Endocrine, 2013, Volume: 43, Issue:2

    Topics: Adrenal Gland Neoplasms; Adrenalectomy; Adult; Carcinoma, Medullary; Dihydroxyphenylalanine; Female;

2013
Diagnostic impact of PET with 18F-FDG, 18F-DOPA and 3-O-methyl-6-[18F]fluoro-DOPA in recurrent or metastatic medullary thyroid carcinoma.
    European journal of nuclear medicine and molecular imaging, 2007, Volume: 34, Issue:10

    Topics: Adult; Aged; Carcinoma, Medullary; Dihydroxyphenylalanine; Female; Fluorodeoxyglucose F18; Humans; M

2007
Dopa decarboxylase in medullary carcinoma of the thyroid.
    The New England journal of medicine, 1973, Sep-13, Volume: 289, Issue:11

    Topics: Adrenal Gland Neoplasms; Amine Oxidase (Copper-Containing); Aromatic Amino Acid Decarboxylase Inhibi

1973
[Hydroxytryptamine in human thyroid gland neoplasms developing from the C-cells].
    Vestnik Akademii meditsinskikh nauk SSSR, 1971, Volume: 26, Issue:8

    Topics: Amyloidosis; Dihydroxyphenylalanine; Humans; Microscopy, Fluorescence; Serotonin; Thyroid Neoplasms

1971